Is PT-141 legal in Australia?

PT-141 (bremelanotide) is a Schedule 4 prescription-only substance and is not registered on the ARTG. It can be lawfully prescribed by an AHPRA-registered Australian doctor under the TGA Special Access Scheme Category B and dispensed by a TGA-licensed Australian compounding pharmacy. Importing it yourself from an offshore vendor is not lawful.

Do I need a prescription for PT-141?

Yes. As a Schedule 4 substance, PT-141 requires a prescription from an AHPRA-registered Australian doctor. There is no lawful over-the-counter or 'research use only' route in Australia.

How is PT-141 different from Viagra or Cialis?

PDE5 inhibitors such as sildenafil (Viagra) and tadalafil (Cialis) improve blood flow to support erectile function. Bremelanotide acts centrally on melanocortin pathways associated with sexual desire and arousal, so it targets a different part of the problem. They are not interchangeable, and your doctor may consider a registered ARTG medicine first.

How much does PT-141 cost in Australia?

The initial telehealth consult is $99. The compounded vial is charged separately by the TGA-licensed pharmacy and varies by dose and quantity — most compounded peptides fall between roughly AUD $90 and $260 per vial. Your prescriber and pharmacy confirm the exact figure before dispensing.

What are the side effects of PT-141?

Nausea is the most commonly reported effect, particularly at higher doses. Flushing, headache, injection-site reactions and a transient rise in blood pressure with a fall in heart rate can also occur, and skin or mole darkening has been reported with repeated use. It is not suitable for people with uncontrolled hypertension or known cardiovascular disease.

Can I get PT-141 prescribed by telehealth in Australia?

Yes, where the consult is genuine and conducted by an AHPRA-registered Australian doctor who lodges the TGA SAS-B notification before dispensing. Sexual health assessment includes blood pressure and cardiovascular history, so your doctor may request readings or baseline pathology before prescribing.

AHPRA-registered doctor · TGA SAS-B pathway

PT-141 (Bremelanotide) in Australia

Get PT-141 assessed and, where clinically appropriate, prescribed lawfully in Australia by an AHPRA-registered doctor under the TGA Special Access Scheme Category B (SAS-B). $99 initial telehealth consult, cold-chain dispense from a TGA-licensed Australian compounding pharmacy.

Start free 5-min assessment How it works

AHPRA-registered doctors

Sexual health concerns are assessed properly first — cardiovascular risk, blood pressure, medications and underlying causes — before any peptide is considered.

TGA SAS-B pathway

Bremelanotide is not on the ARTG in Australia, so an Australian doctor accesses it per-patient under SAS-B with a TGA notification lodged before dispensing.

Australian compounding

Dispensed by a TGA-licensed compounding pharmacy under PIC/S GMP — batch-tested for identity, sterility and potency. No offshore vials.

What is PT-141?

PT-141 (bremelanotide) is a synthetic peptide analogue of alpha-melanocyte-stimulating hormone that acts on melanocortin receptors in the central nervous system. Unlike PDE5 inhibitors such as sildenafil, which work on blood flow in the periphery, bremelanotide acts centrally on pathways involved in sexual desire and arousal. It is administered as a subcutaneous injection on an as-needed basis rather than daily.

Bremelanotide is approved in the United States (as Vyleesi) for acquired, generalised hypoactive sexual desire disorder in premenopausal women. It is not registered on the Australian Register of Therapeutic Goods. That does not make it illegal in Australia — it means an AHPRA-registered Australian doctor must access it for an individual patient under the TGA Special Access Scheme Category B, with the notification lodged before a TGA-licensed compounding pharmacy dispenses it.

Sexual difficulties frequently have treatable underlying causes — medication side effects, low testosterone, thyroid or cardiovascular disease, depression, relationship or sleep factors. A responsible Australian prescriber works through those first. PT-141 is considered only where a clinical assessment supports it.

Typical clinical indications

Low sexual desire where reversible medical and medication causes have been reviewed
Arousal difficulties not adequately addressed by PDE5 inhibitors
Patients in whom PDE5 inhibitors are unsuitable or poorly tolerated, subject to clinical review
Adjunct to management of underlying contributors (hormonal, psychological, lifestyle)

Administration

Subcutaneous injection taken as needed, typically well ahead of anticipated activity rather than on a daily schedule. Dose and maximum frequency per month are set by your prescriber — bremelanotide is not intended for frequent repeated dosing, and self-escalating the dose increases nausea and blood-pressure effects.

Cautions and contraindications

Not suitable in uncontrolled hypertension or known cardiovascular disease — bremelanotide can cause a transient rise in blood pressure and fall in heart rate. Nausea is the most commonly reported effect, along with flushing, headache and injection-site reactions; darkening of skin or existing moles has also been reported with repeated use. Not for use in pregnancy or breastfeeding. Disclose all current medications, including nitrates and blood-pressure medicines, at consult.

How to get PT-141 prescribed in Australia

1. Free 5-minute pre-qualification
Answer screening questions about your history, goals, and current medications. Instant suitability check.
2. $99 telehealth consult
Video or phone consult with an AHPRA-registered Australian doctor. They review eligibility and confirm dosing.
3. SAS-B script issued (24–48 hours)
Doctor lodges a TGA SAS-B notification and routes the script to a TGA-licensed Australian compounding pharmacy.
4. Cold-chain dispense (2–4 business days)
Pharmacy ships cold-chain Mon–Wed. Includes vials, syringes, alcohol swabs, and a starter guide.

Do not import PT-141 from overseas

Importing PT-141 yourself from offshore "research chemical" vendors is illegal under the Customs Act, gives no guarantee of sterility or potency, and leaves you with no Australian doctor if something goes wrong. The lawful path is AHPRA-registered doctor → TGA SAS-B → TGA-licensed Australian compounding pharmacy. See why staying local matters.

PT-141 Australia — FAQs

Is PT-141 legal in Australia?: PT-141 (bremelanotide) is a Schedule 4 prescription-only substance and is not registered on the ARTG. It can be lawfully prescribed by an AHPRA-registered Australian doctor under the TGA Special Access Scheme Category B and dispensed by a TGA-licensed Australian compounding pharmacy. Importing it yourself from an offshore vendor is not lawful.
Do I need a prescription for PT-141?: Yes. As a Schedule 4 substance, PT-141 requires a prescription from an AHPRA-registered Australian doctor. There is no lawful over-the-counter or 'research use only' route in Australia.
How is PT-141 different from Viagra or Cialis?: PDE5 inhibitors such as sildenafil (Viagra) and tadalafil (Cialis) improve blood flow to support erectile function. Bremelanotide acts centrally on melanocortin pathways associated with sexual desire and arousal, so it targets a different part of the problem. They are not interchangeable, and your doctor may consider a registered ARTG medicine first.
How much does PT-141 cost in Australia?: The initial telehealth consult is $99. The compounded vial is charged separately by the TGA-licensed pharmacy and varies by dose and quantity — most compounded peptides fall between roughly AUD $90 and $260 per vial. Your prescriber and pharmacy confirm the exact figure before dispensing.
What are the side effects of PT-141?: Nausea is the most commonly reported effect, particularly at higher doses. Flushing, headache, injection-site reactions and a transient rise in blood pressure with a fall in heart rate can also occur, and skin or mole darkening has been reported with repeated use. It is not suitable for people with uncontrolled hypertension or known cardiovascular disease.
Can I get PT-141 prescribed by telehealth in Australia?: Yes, where the consult is genuine and conducted by an AHPRA-registered Australian doctor who lodges the TGA SAS-B notification before dispensing. Sexual health assessment includes blood pressure and cardiovascular history, so your doctor may request readings or baseline pathology before prescribing.

Related Australian peptide pages

Start with the legality hub if you're new to TGA SAS-B prescribing, or browse the other Australian peptide landings.

Are peptides legal in Australia? — TGA SAS-B explained Free 60-sec eligibility checker

Medically reviewed by the PeptideDoctorAU Medical Review Panel — last reviewed 29 May 2026. See the panel.

Start your PT-141 consult — $99

Take the free 5-minute pre-qualification. If you're suitable, you'll be matched with an AHPRA-registered Australian doctor for a $99 telehealth consult — TGA SAS-B prescribing, Australian-compounded vial.

Start free assessment